About us Contact Terms of Use Data Sources Publications FAQ
RIN2 logo

RIN2

Ras and Rab interactor 2

Copy number variation

DiseaseSignal Cell linesGain Cell linesAvg. ampLoss Cell linesAvg. lossNo-signal Cell linesAvg. change
cancer 1 0 1 0.48 146 1.11
NS 1 0 1 0.48 152 1.16
carcinoma 6 3 2.10 3 0.30 546 1.12
haematopoietic_neoplasm 0 0 0 63 1.02
leukaemia 0 0 0 84 1.04
lymphoid_neoplasm 0 0 0 135 1.05
glioma 0 0 0 52 1.18
malignant_melanoma 0 0 0 56 1.22
melanoma 0 0 0 43 1.20
glioblastoma 0 0 0 2 0.85

Cell lines

Cell lineSignalCopy numberAvg. genome ploidyAmplificationDiseaseTissue
22Rv-1 No signal 2 2.04 0.98 cancer, NS, carcinoma prostate
5637 No signal 4 2.99 1.34 cancer, carcinoma bladder, urinary_tract
639-V No signal 4 2.41 1.66 cancer, carcinoma bladder, ureter, urinary_tract
647-V No signal 4 2.50 1.60 cancer, carcinoma bladder, urinary_tract
697 No signal 2 1.98 1.01 haematopoietic_neoplasm, leukaemia, lymphoid_neoplasm blood_bone_marrow, haematopoietic_and_lymphoid_tissue
769-P No signal 2 1.97 1.02 carcinoma kidney
786-0 No signal 4 3.82 1.05 cancer, carcinoma kidney
8-MG-BA No signal 2 2.20 0.91 glioma brain, central_nervous_system
8305C No signal 6 3.09 1.94 carcinoma thyroid
8505C No signal 5 3.00 1.67 carcinoma thyroid